# Prevention of RSV Infections in Bone Marrow Transplant Recipients

> **NCT00001903** · PHASE4 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 120 (—)

## Conditions studied

- Respiratory Syncytial Virus Infection

## Interventions

- **DRUG:** RSV Polyclonal Immunoglobulin

## Key facts

- **NCT ID:** NCT00001903
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04
- **Primary completion:** —
- **Final completion:** 2001-05
- **Target enrollment:** 120 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001903, "Prevention of RSV Infections in Bone Marrow Transplant Recipients". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00001903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*